Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Improving Colorectal Cancer Early Screening in Portugal: Identification and Validation of Biomarkers of Gut Microbiome in Stool

NCT06741293 is registered in ClinicalTrials.gov with Gulbenkian Institute for Molecular Medicine as lead sponsor.

NCT NCT06741293
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06741293 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Improving Colorectal Cancer Early Screening in Portugal: Identification and Validation of Biomarkers of Gut Microbiome in Stool
Lead sponsor
Gulbenkian Institute for Molecular Medicine
Phase
Observational
Overall status
Recruiting
Start date
November 28, 2023
Completion date
November 28, 2029
Enrollment
30,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal cancer (crc), colorectal cancer screening, microbiome